Search

Displaying results 7391 - 7400 of 7460 in total
  1. Drug

    Myrcludex B

    go.drugbank.com/drugs/DB14853
    Investigational

    Clinical Study to Assess Efficacy and Safety of 3 Doses of Myrcludex B for 24 Weeks in Combination With Tenofovir Compared to Tenofovir Alone to Suppress HBV Replication in Patients With Chronic Hepatitis D)

  2. Drug

    Leptazoline A

    go.drugbank.com/drugs/DB15551
    Experimental

    Also see [Leptazoline B], [Leptazoline C], and [Leptazoline D].

  3. Drug

    Leptazoline B

    go.drugbank.com/drugs/DB15552
    Experimental

    Also see [Leptazoline A], [Leptazoline C], and [Leptazoline D].

  4. Drug

    Leptazoline C

    go.drugbank.com/drugs/DB15553
    Experimental

    Also see [Leptazoline A], [Leptazoline B], and [Leptazoline D].

  5. Drug

    BCX10013

    go.drugbank.com/drugs/DB18496
    Investigational

    BCX10013 is a small molecule inhibitor of human complement factor D.

  6. Drug

    Zelpultide alfa

    go.drugbank.com/drugs/DB18587
    Investigational

    Zelpultide alfa is a recombinant human surfactant protein D.

    Synonyms: RECOMBINANT SP-D, HUMAN PULMONARY SURFACTANT-ASSOCIATED PROTEIN D (PSPD, SURFACTANT PROTEIN D, SP-D, COLLECTIN-7, SURFACTANT PROTEIN D), NON-COVALENT QUADRUPLE TRIMER, PRODUCED IN HUMAN MYELOGENOUS LEUKEMIA K562 CELLS,
  7. Drug

    CL-315585

    go.drugbank.com/drugs/DB18758
    Experimental

    CL-315585 is the D isomer of [Verteporfin].

    Synonyms: Bpd-ma(sub d), Verteporfin d isomer
  8. Drug

    Elebsiran

    go.drugbank.com/drugs/DB19018
    Investigational

    Elebsiran is under investigation in clinical trial NCT05461170 (SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.).

  9. Drug

    Yeast beta-D-glucan

    go.drugbank.com/drugs/DB19271
    Investigational

    Yeast beta-D-glucan is under investigation in clinical trial NCT00632008 (Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers).

    Synonyms: -d-glucopyranose, Beta-1,3-1,6-d-glucan
  10. Drug

    Alglucerase

    go.drugbank.com/drugs/DB00088
    ApprovedWithdrawn

    Human Beta-glucocerebrosidase or Beta-D-glucosyl-N-acylsphingosine glucohydrolase E.C. 3.2.1.45. 497 residue protein with N-linked carbohydrates, MW=59.3 kD.